Imprinted CDKN1C Is a Tumor Suppressor in Rhabdoid Tumor and Activated by Restoration of SMARCB1 and Histone Deacetylase Inhibitors

Elizabeth M. Algar, Andrea Muscat, Vinod Dagar et al. · 2009

Read Imprinted CDKN1C Is a Tumor Suppressor in Rhabdoid Tumor and Activated by Restoration of SMARCB1 and Histone Deacetylase Inhibitors by Elizabeth M. Algar, Andrea Muscat, Vinod Dagar et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0004482.txt.

Description

A silenced gene that brakes cell growth can be switched back on in a rare childhood tumor, report Elizabeth Algar, Andrea Muscat, Vinod Dagar, and co-authors in PLOS ONE in 2009. The tumor is rhabdoid tumor, an aggressive cancer of the kidney and brain in young children. It is defined by the loss of a gene called SMARCB1, which helps control how DNA is packaged.

The missing gene seems to let other controls be silenced, including CDKN1C, a tumor suppressor imprinted from one parent. Restoring SMARCB1, or using drugs that block histone deacetylases, turned CDKN1C back on in the team's tests. That reawakening suggests a treatment angle for a tumor that now has few. It also shows how one lost gene can mute a whole safety system.

Catalog record

CREATORElizabeth M. Algar, Andrea Muscat, Vinod Dagar et al.
YEAR2009
COLLECTIONPAPERS
FORMATTXT
FILE SIZE69 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0004482

Browse the full library · About the Tower of Babel